Kleopatra Rapti Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty University of Heidelberg Biography Publications Institution JoVE Articles Kleopatra Rapti has not added a biography. If you are Kleopatra Rapti and would like to personalize this page please email our Author Liaison for assistance. Publications Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the Hedgehog Frontiers in Immunology. 2021 | Pubmed ID: 34777364 A Universal Protocol for Isolating Retinal ON Bipolar Cells Across Species Via Fluorescence-activated Cell Sorting Molecular Therapy. Methods & Clinical Development. Mar, 2021 | Pubmed ID: 33665228 Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K Channel-Related Acid-Sensitive K Channel-1) (K3.1) K Channels Suppresses Atrial Fibrillation and Prevents Electrical Remodeling Circulation. Arrhythmia and Electrophysiology. 09, 2019 | Pubmed ID: 31514528 Cell-specific CRISPR-Cas9 Activation by MicroRNA-dependent Expression of Anti-CRISPR Proteins Nucleic Acids Research. 07, 2019 | Pubmed ID: 30982889 Comprehensive Plasma and Tissue Profiling Reveals Systemic Metabolic Alterations in Cardiac Hypertrophy and Failure Cardiovascular Research. 07, 2019 | Pubmed ID: 30418544 Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy Circulation. Genomic and Precision Medicine. 03, 2018 | Pubmed ID: 29545480 Cell-Based Measurement of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Methods in Molecular Biology (Clifton, N.J.). 2017 | Pubmed ID: 27910044 Locally Targeted Cardiac Gene Delivery by AAV Microbubble Destruction in a Large Animal Model Human Gene Therapy Methods. Apr, 2016 | Pubmed ID: 26971929 Isolement de vecteurs de thérapie génique de nouvelle génération par l’ingénierie, le codage à barres et le criblage de variantes de capside du virus adéno-associé (AAV) Kleopatra Rapti1,2, Olena Maiakovska1,2, Jonas Becker1,2, Joanna Szumska1,2, Margarita Zayas1,2, Felix Bubeck1,2, Jixin Liu1,2, Emma Gerstmann1,2, Chiara Krämer1,2, Ellen Wiedtke1,2, Dirk Grimm1,2,3,4,5 1Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, University of Heidelberg, 2BioQuant Center, BQ0030, University of Heidelberg, 3Cluster of Excellence CellNetworks, 4German Center for Infection Research (DZIF), 5German Center for Cardiovascular Research (DZHK) JoVE 64389 Bioengineering
Isolement de vecteurs de thérapie génique de nouvelle génération par l’ingénierie, le codage à barres et le criblage de variantes de capside du virus adéno-associé (AAV) Kleopatra Rapti1,2, Olena Maiakovska1,2, Jonas Becker1,2, Joanna Szumska1,2, Margarita Zayas1,2, Felix Bubeck1,2, Jixin Liu1,2, Emma Gerstmann1,2, Chiara Krämer1,2, Ellen Wiedtke1,2, Dirk Grimm1,2,3,4,5 1Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, University of Heidelberg, 2BioQuant Center, BQ0030, University of Heidelberg, 3Cluster of Excellence CellNetworks, 4German Center for Infection Research (DZIF), 5German Center for Cardiovascular Research (DZHK) JoVE 64389 Bioengineering